Remove production batch
article thumbnail

Nexcella Begins Production of CAR-T Cell Therapy Engineering Batches at US Manufacturing Site

PharmaTech

The start of production of US engineering batches of NXC-201, a CAR-T cell therapy candidate in early clinical development, is the first step in transferring Nexcella’s existing manufacturing process to the United States.

52
article thumbnail

STAT+: IVF doctors demand full details on fluid that grows embryos amid CooperSurgical lawsuits

STAT

CooperSurgical acknowledged that the batch of fluid may have stunted embryo growth in a product recall notice , but it hasn’t disclosed exactly what went wrong. The fluid, called culture media, is filled with nutrients that allow embryos to develop enough to ultimately be implanted into a uterus.

Labelling 286
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: STAT+: Continuous manufacturing can help pharma companies save time, money, and more

STAT

Continuous manufacturing produces a drug product from start to finish through a nonstop, integrated assembly. In contrast, most of the pharmaceutical industry currently uses batch manufacturing, which involves producing a finished drug product through multiple distinct steps in series.

article thumbnail

Oestrogel recalled from pharmacies over faulty pump

The Pharmacist

Two batches of Oestrogel Pump-Pack 750 micrograms/actuation Gel (estradiol) produced by Besins Healthcare (UK) Ltd have been recalled from pharmacies over issues with the pump mechanism.

79
article thumbnail

STAT+: Catalent is scolded by FDA for quality control issues at a plant that helps make Covid-19 vaccines

STAT

Following a recent month-long inspection, the agency scolded Catalent for various problems, such as failing to investigate unexplained discrepancies in batches of products and to ensure that product sampling and testing met quality control criteria.

Vaccines 202
article thumbnail

WHO flags Cold Out cough syrup over higher limits of diethylene and ethylene glycol

Express Pharma

The World Health Organization flagged a batch of contaminated common cold syrup, manufactured by an Indian company on Monday. The batch had 0.25 per cent, WHO said in its medical product alert. The batch had 0.25 per cent, WHO said in its medical product alert. per cent of diethylene glycol and 2.1

92
article thumbnail

Pharmatech Insights – Business Considerations for Pharmaceutical Continuous Manufacturing

PharmaTech

Continuous Manufacturing in pharmaceuticals can increase process understanding while overcoming disadvantages of batch manufacturing: slow and expensive development and tech transfer, plus inefficiencies, product loss, and human error in commercial manufacturing.

52